US Bancorp’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-25
| Closed | – | – | 3759 |
|
|
2019
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 3775 |
|
|
2018
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 3832 |
|
|
2018
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 3795 |
|
|
2018
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 3800 |
|
|
2018
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 3808 |
|
|
2017
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 3776 |
|
|
2017
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 3727 |
|
|
2017
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 3691 |
|
|
2017
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 3524 |
|
|
2016
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 3511 |
|
|
2016
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 3500 |
|
|
2016
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 3521 |
|
|
2016
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 3413 |
|
|
2015
Q4 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 3482 |
|